Mirae Asset Global Investments
PJP icon

Mirae Asset Global Investments’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Mirae Asset Global Investments’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,595
Closed -$167K – 1702
2025
Q4 		$167K Buy
+1,595
New +$160K ﹤0.01% 1174
2022
Q4 		– Sell
-116,300
Closed -$8.29M – 2578
2022
Q3 		$8.29M Buy
+116,300
New +$8.67M 0.02% 646

Other funds holding PJP

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $2.41B AUM 38.24% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Mirae Asset Global Investments's PJP Position: Q1 2026 in Review

Mirae Asset Global Investments sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2026, closing a stake of 1,595 shares — an estimated $167K sold.

Mirae Asset Global Investments first reported a position in PJP in Q3 2022 and held it in 2 quarters. The position peaked at $8.29M in Q3 2022. 119 funds tracked by Wall St. Rank hold PJP as of Q1 2026.

  • Mirae Asset Global Investments reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2026 after selling out during the quarter.
  • Mirae Asset Global Investments sold 1,595 Invesco Pharmaceuticals ETF shares in Q1 2026, an estimated $167K.
  • Mirae Asset Global Investments first reported a position in Invesco Pharmaceuticals ETF in Q3 2022 and held it in 2 quarters.
  • Mirae Asset Global Investments's Invesco Pharmaceuticals ETF position peaked at $8.29M in Q3 2022.
  • 119 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2026.

Based on Mirae Asset Global Investments's 13F filing for Q1 2026, filed 4 May 2026.